In a significant development for Ripple, Wellgistics Health, a Nasdaq-listed healthcare firm, has filed an S-1 form with the SEC, outlining a $50 million plan to integrate XRP and the XRP Ledger (XRPL) into its core operations.
The initiative, backed by a $50 million fund from LDA Capital, aims to leverage XRP for B2B transactions, treasury reserves, collateral, and capital-raising activities, marking a shift from speculative to utility-driven use of the cryptocurrency. This move has contributed to a 12.6% surge in XRP’s price, reflecting market optimism about its growing real-world utility.
Crypto expert Bill Morgan highlighted that Wellgistics plans to use XRP for fast, low-cost payments, fundraising through share sales to acquire more $XRP , and as loan collateral, emphasizing its practical application. However, former SEC official Marc Fagel raised concerns about Wellgistics’ financial health, citing minimal assets and a “going concern” warning, suggesting the strategy might be a capital-raising tactic rather than a genuine operational shift. This filing positions XRP as a strategic financial asset, potentially paving the way for broader corporate adoption, though skepticism about the firm’s credibility persists.
